Industry Experts

Sujiet Puthenveetil is a Director at AstraZeneca, where he leads a dynamic, multidisciplinary team focused on advancing targeted delivery technologies in Oncology and other therapeutic areas. He manages highly productive teams of Protein engineers, Analytical chemists, Radiochemists, Synthetic chemists, and Bioconjugation scientists, centered on driving the development of Antibody-Drug Conjugates (ADC), Antibody-Oligo Conjugates (AOC), and Radioligand Therapies (RLT) into clinical trials, with notable projects such as AZD9829 and FPI-2068.